ILIKETA wrote:
Under accounting rules, fair value adjustments for cannabis companies count newly produced marijuana/cannabis products as revenue (before it is even sold), minus production expenses.
Q1 (July Aug Sept) - reports at the end of Nov
So we should see a very large increase in revenues for this quarter because it should include:
- the autoflower harvest (estimated at about 1/10th of the outdoor harvest)
- sales from the OCS, the SQDC and the AGLC
- sales from Quill
- sales to Canopy Growth
- etc
Cannabis Summary for Oct. 15, 2019
2019-10-15 21:36 ET - Market Summary
This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.
Here is a sample of this item:
by Stockwatch Business Reporter
The Canadian Securities Exchange Composite Index rose 12.52 points to 452.36 Tuesday, lifted by positive results from Aphria Inc. (APHA). Aphria jumped 96 cents to $7.17 on 13.3 million shares after reporting its second straight profitable quarter. The company earned $16.4-million in the fiscal first quarter (ended Aug. 31, 2019), up from earnings of $15.8-million in fiscal Q4. Aphria's $16.4-million profit from this quarter is largely the result of fair value adjustments. (Under accounting rules, fair value adjustments for cannabis companies count newly produced marijuana/cannabis products as revenue (before it is even sold), minus production expenses.) The company had a net gain of $17.8-million on these fair value adjustments in fiscal Q1.
Aphria's total revenue of $126.1-million in fiscal Q1 was slightly down from the $128.6-million that it recorded in the previous quarter, and below analyst expectations of $130.6-million. The decrease is the result of a small decline in revenue from Aphria's German distribution business, CC Pharma. That decline was partially offset by increased net revenue on cannabis sales, which reached $30.8-million in Q1, up from $28.6-million. It could have been a more significant increase, but Aphria lost an estimated $1.5-million of cannabis sales as a result of a fire at its Broken Coast facility on Vancouver Island. While Aphria's cannabis sales were up, so were its costs to produce that cannabis; Aphria spent $1.43 per gram in fiscal Q1, compared with $1.35 in the quarter before.
[url=https://www.stockwatch.com/News/Item.aspx?bid=Z-C:*MKTPOT-2819851&symbol=*MKTPOT®ion=C]https://www.stockwatch.com/News/Item.aspx?bid=Z-C:*MKTPOT-2819851&symbol=*MKTPOT®ion=C[/url]